Association of post-traumatic epilepsy with outcomes in individuals with severe traumatic brain injury | Department of Neurology (pitt.edu)
The research team hopes that early, aggressive epilepsy screening and efficient treatment of severe TBI in patients can lead to improved functional outcomes after brain injury. James F. Castellano, MD, PhD, author, says, “Our results underscore the importance of the prompt identification and management of epilepsy in patients who have suffered traumatic brain injury.”
Hu Receives RF1 Award from NINDS and NIA | Department of Neurology (pitt.edu)
Xiaoming Hu, MD, an associate professor at the University of Pittsburgh Department of Neurology, is the recipient of a three-year RF1 award for the study, “White matter injury and repair in vascular cognitive impairment and dementia.”
New Blood Biomarker Can Predict if Cognitively Healthy Elderly Will Develop Alzheimer’s Disease | UPMC Physician Resources
Star-shaped brain cells called astrocytes are key to swaying the pendulum in Alzheimer’s disease progression, shows new game-changing research published in Nature Medicine.
Exposure to Antiseizure Medications Does Not Harm Neurological Development in Young Children | UPMC Physician Resources
Most mothers who took prescription antiseizure medications during pregnancy can breathe a sigh of relief: A new study published in Lancet Neurology found that young children who were exposed to commonly-prescribed medications in utero do not have worse neurodevelopmental outcomes than children of healthy women. Page B. Pennell, MD, was senior author of the study.
Yin Receives NIH R01 Award and AHA Transformational Project Award | Department of Neurology (pitt.edu)
Kejie Yin, MD, PhD, an associate professor at the University of Pittsburgh Department of Neurology, is the recipient of a five-year R01 award for the study, “Targeting Krüppel-like transcription factor for white and grey matter protection in vascular cognitive impairment and dementia.”
Pitt and UPMC Partner to De-Risk Disease Therapies
As a clinician, Dr. Ed Burton operates a pre-eminent clinic for sufferers of progressive supranuclear palsy (PSP), a debilitating and fatal neurodegenerative disease with no effective treatments. And as principal investigator for the Pittsburgh Institute for Neurodegenerative Diseases at the University of Pittsburgh, he is working tirelessly to change that.
He has formed a cross-disciplinary collaboration with Donna Huryn, Professor in the Department of Pharmaceutical Sciences at the School of Pharmacy, to create a class of molecules that combat the damage to neurons caused by the disease.
N3-PREP to Train Next Generation of Physician-Scientists | Department of Neurology (pitt.edu)
The University of Pittsburgh Departments of Neurology and Neurological Surgery and Division of Neuropathology have been awarded a five-year NIH NINDS R25 Research Education Grant to help advance academic research careers in neuroscience.
Irritability, Agitation and Anxiety in Alzheimer’s Patients Caused by Brain Inflammation, Pitt Study Says | UPMC Physician Resources
Common neuropsychiatric symptoms that doctors see in Alzheimer’s disease patients originate from brain inflammation rather than amyloid and tau proteins, report University of Pittsburgh School of Medicine researchers in JAMA Network Open.
Recent Publications | Department of Neurology (pitt.edu)
With a staff of award-winning physicians, researchers, and faculty, the Department of Neurology continues to publish groundbreaking research across key topics in the field. Read about some of the research advances the Department has made recently.
UPMC Department of Neurology Research Review: December 2023 | UPMC Physician Resources
Research topics for December 2023 focused on improving stroke outcomes, challenging clots, disorders of consciousness, and more.
Predicting Alzheimer’s Dementia in Oldest of the Old | UPMC Physician Resources
A new study indicates that severity of amyloid deposition in the brain — not just age — may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer’s disease. Oscar Lopez, MD, was a corresponding author of the study.
UPMC Presbyterian Shadyside Nationally Ranked for Excellence in Neurology and Neurosurgery
